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In this study, we provide evidence that endoplasmic reticulum (ER) stress suppresses DNA double-
strand break (DSB) repair and increases radiosensitivity of tumor cells by altering Rad51 levels. We
show that the ER stress inducer tunicamycin stimulates selective degradation of Rad51 via the 26S
proteasome, impairing DSB repair and enhancing radiosensitivity in human lung cancer A549 cells.
We also found that glucose deprivation, which is a physiological inducer of ER stress, triggered sim-
ilar events. These ﬁndings suggest that ER stress caused by the intratumoral environment inﬂuences
tumor radiosensitivity, and that it has potential as a novel target to improve cancer radiotherapy.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A number of cellular stresses lead to accumulation of unfolded
and/or misfolded proteins in the ER lumen and cause so-called ER
stress [1–3]. ER stress activates various intracellular signaling
pathways, known as the unfolded protein response (UPR) [1–3].
When cells undergo ER stress, the UPR triggers three main re-
sponses: the inhibition of general protein translation, the induction
of genes such as ER chaperones to increase the protein-folding
capacity of the ER, and up-regulation of aberrant protein degrada-
tion in the ER. The last process is called ER-associated degradation
(ERAD). The ERAD system eliminates aberrant proteins via degra-
dation in the cytosol [4]. Aberrant ER proteins are retrotranslocated
across the ER membrane into the cytosol, where ubiquitin-conju-
gating enzymes target them for proteasomal degradation [5]. Fun-
damentally, UPR is a cyto-protective response. However, excessive
or prolonged UPR results in cell death. The UPR pathways are acti-
vated in a variety of tumor types, and are essential for tumor cellsto survive the unfavorable environment of solid tumors, which is
typically characterized by hypoxia, low pH, and nutrient depriva-
tion [3,6,7]. In addition, recent evidence suggests that the UPR is
an important mechanism required for cancer cells to maintain
malignancy and therapy resistance [3,7].
In cancer radiotherapy, DNA damage caused by ionizing radia-
tion (IR) and inherent DNA repair capacity of tumor cells are
important factors that determine therapeutic outcome. Therefore,
interfering with the DNA repair machinery of tumor cells is one
of the major strategies to treat cancer [8]. Among the various types
of DNA damage induced by IR, DSB is regarded as the most lethal to
the cell [8,9]. In mammalian cells, DSBs are repaired by one of two
distinct processes, known as non-homologous end joining (NHEJ)
or homologous recombination (HR) [9]. Rad51, a recA homolog
that binds the single-strand DNA generated by Mre11–Rad50–
NBS1 complex, is essential for recombinational repair. Cells lacking
functional Rad51 are unable to form subnuclear foci, characteristic
of HR, and are signiﬁcantly more sensitive to IR [10,11]. Further-
more, elevated Rad51 expression in tumor tissues is associated
with an unfavorable prognosis in lung cancer [12]. These observa-
tions indicate that Rad51 is a promising target to improve the ther-
apeutic efﬁcacy of radiotherapy. This concept is partly supported
by our recent study demonstrating that a novel anticancer drug,
TAS106, radiosensitized tumor cells by down-regulating Rad51
and Brca2 expression [13].
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due to the surrounding environment may affect the outcome of
various anticancer strategies. For example, it has been reported
that ER stress inﬂuences chemosensitivity of tumor cells to anti-
cancer drugs such as cisplatin and doxorubicin [14,15]. In addition,
Contessa et al. have shown that the classic ER stress inducer
tunicamycin causes radiosensitization in tumor cells, but not in
normal cells [16]. However, it remains unclear how ER stress inﬂu-
ences DSB repair capacity and radiosensitivity of tumor cells.
Therefore, we sought to decipher the effect of ER stress using dif-
ferent types of ER stress-inducing treatments.
2. Materials and methods
2.1. Reagents
Regular and glucose-free RPMI 1640 medium were purchased
from Invitrogen (Carlsbad, CA, USA). Tunicamycin was obtained
from Enzo Life Sciences (Farmingdale, NY, USA), and cisplatin
was obtained from Wako Pure Chemical Industries (Osaka, Japan).
MG132 was purchased from Cayman Chemical (Ann Arbor, MI,
USA). ALLN was obtained from Merck (Darmstadt, Germany). Pro-
tein A Sepharose was obtained from GE healthcare (Buckingham-
shire, UK). The following antibodies were used for Western
blotting and immunostaining: anti-NBS1, anti-Mre11 (Abcam,
Cambridge, MA, USA), anti-phospho-eIF2a, anti-c-H2AX (Cell Sig-
naling Technology, Beverly, MA, USA), anti-Rad51, anti-DNA-PKcs,
anti-Ku70, anti-actin, anti-ubiquitin, HRP-conjugated secondary
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
Alexa Fluor 488 anti-rabbit IgG (Invitrogen). The chemilumines-
cence detection kit, Western Lightning Plus-ECL, was purchased
from Perkin–Elmer (Boston, MA, USA).
2.2. Cell culture and X-irradiation
The human lung carcinoma cell line A549 was grown in RPMI
1640 containing 10% fetal bovine serum at 37 C in 5% CO2. X-irra-
diation was performed with a Shimadzu PANTAK HF-350 X-ray
generator (Shimadzu, Kyoto, Japan) at 200 kVp, 20 mA with a
1.0-mm aluminum ﬁlter.
2.3. SDS–PAGE and Western blotting
Cells were collected and lysed in lysis buffer (20 mM HEPES–
NaOH [pH 7.4], 2 mM EGTA, 50 mM b-glycerophosphate, 1% Triton
X-100, 10% glycerol, 1 mM PMSF, 10 lg/ml leupeptin, 10 lg/ml
aprotinin and 10 lg/ml pepstatin). After centrifugation at 20000g
for 15 min at 4 C, supernatants were collected. Threefold concen-
trated Laemmli’s sample buffer (0.1875 M Tris–HCl [pH 6.8], 15% b-
mercaptoethanol, 6% SDS, 30% glycerol and 0.006% bromophenol
blue) was added to the supernatants, and the samples were boiled
for 5 min. Proteins were separated by SDS–PAGE and transferred
onto a nitrocellulose membrane (Advantec Toyo, Tokyo, Japan).
The membrane was probed with speciﬁc antibodies diluted with
TBST (10 mM Tris–HCl [pH 7.4], 0.1 M NaCl and 0.1% Tween-20)
containing 5% non-fat skim milk, overnight at 4 C. After probing
with HRP-conjugated secondary antibodies, bound antibodies were
detected with Western Lightning Plus-ECL (Perkin–Elmer).2.4. Semi-quantitative reverse transcription-PCR (RT-PCR)
Total RNA was extracted and puriﬁed with an RNeasy Mini Kit
(Qiagen, Hilden, Germany) according to themanufacturer’s instruc-
tions. One microgram of RNA was reverse transcribed using a
Reverse Transcription System (Promega, Madison, WI, USA) andresulting cDNAampliﬁedwithGoTaq™DNAPolymerase (Promega).
The speciﬁc primer sequences for PCR were as follows: for Rad51,
50-TTTGGAGAATTCCGAACTGG-30 and 50-AGGAAGACAGGGAGAGT
CG-30; for actin 50-GACCCAGATCATGTTTGAGACC-30 and 50-GGT
GAGGATCTTCATGAGGTAG-30.The PCR proﬁle was as follows: initial
denaturation at 95 C for 2 min, followed by 31 cycles (actin) or 40
cycles (Rad51) at 95 C for 1 min, annealing at 63 C (actin) or
64 C (Rad51) for 1 min and extension at 72 C for 1 min. The ﬁnal
extension was performed by incubation at 72 C for 5 min. PCR
products were subjected to agarose gel electrophoresis and
visualized using ethidium bromide (Sigma, St. Louis, MO, USA).
2.5. Immunoﬂuorescence staining
At the times indicated following X-irradiation, cells attached on
glass coverslips were ﬁxed with 4% paraformaldehyde/PBS for
30 min at room temperature. After permeabilization with 0.5% Tri-
ton X-100/PBS for 5 min at 4 C, cells were treatedwith PBS contain-
ing 6% goat serum for 30 min at room temperature. Subsequently,
they were incubated with the anti-c-H2AX antibody (1:500) in 3%
goat serum overnight at 4 C. They were then incubated in the dark
with the Alexa Fluor 488-conjugated anti-rabbit secondary anti-
body at a 1:500 dilution for 1.5 h. After incubation, they were coun-
terstainedwith 300 nM40,6-diamidino-2-phenylindole (Invitrogen)
for 5 min at room temperature. Coverslips were mounted with Pro-
long Gold antifade reagent (Invitrogen). Fluorescent microscopic
analysis was performed using an Olympus BX61 microscope with a
reﬂected light ﬂuorescence and foci were counted manually.
2.6. Clonogenic survival assay
Cells were seeded on 6-cm dishes and treated with 5 lM
tunicamycin for 12 h, followed by X-irradiation. Where necessary,
cells were treated with cisplatin for 3 h after tunicamycin treat-
ment. After incubation for 10 days, they were ﬁxed with methanol
and stained with Giemsa solution (Sigma). Colonies containing
more than 50 cells were scored as surviving cells. Surviving frac-
tions were corrected using the plating efﬁciency of the non-irradi-
ated control. The survival curves of X-irradiated cells were
obtained by ﬁtting to a linear-quadratic model using data analysis
software Origin Pro 7 (OriginLab Co., Northampton, MA, USA).
2.7. Rad51 ubiquitination
A549 cells were treated with DMSO or 5 lM tunicamycin in the
presence or absence of 10 lM MG132 for 12 h and lysed in IP lysis
buffer (50 mMTris–HCl [pH7.5], 1% (v/v) TritonX-100, 5% (v/v) glyc-
erol, 5 mMEDTA, 150 mMNaCl, 1 protease inhibitor cocktail (Nac-
alai Tesque, Kyoto, Japan), 10 mM iodoacetamide and 50 lM
MG132).After centrifugationat 20000g for 15 minat 4 C,whole cell
extracts (WCE)were collected.WCEwere rotatedwith Protein A Se-
pharose for 30 min at 4 C and preclearedWCE were collected. Two
micrograms of Rad51 antibody was added to the samples and they
were rotated overnight at 4 C. After 30 ll of 50% slurry Protein A Se-
pharose was added, the samples were rotated for 1 h at 4 C. After
beads were washed 7 times, they were mixed with 3 Laemmli’s
samplebuffer andsubjected toSDS–PAGE, followedby immunoblot-
ting using the speciﬁed primary antibody and the appropriate sec-
ondary antibody.
3. Results
3.1. ER stress suppresses Rad51 levels
To determine whether ER stress affects DSB repair, we exam-
ined the effect of tunicamycin, a classic ER stress inducer, on the
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cancer A549 cells. Since ER stress is known to activate PERK, which
leads to the phosphorylation of eIF2a and suppression of protein
translation [17], we used phospho-eIF2a as a marker of ER stress.
As shown in Fig. 1A, treatment with tunicamycin for 12 h increased
phospho-eIF2a in a concentration-dependent manner, indicating
that tunicamycin caused ER stress in A549 cells, as expected. We
then examined the expression levels of various DSB repair proteins
after tunicamycin treatment and found that it led to a decrease in
Rad51 levels, a key HR pathway protein, in a concentration-depen-
dent manner. Meanwhile, tunicamycin did not alter expression
levels of other HR-related proteins (Mre11 and NBS1) or NHEJ pro-
teins (DNA–PKcs and Ku70). Furthermore, we observed that 5 lM
tunicamycin induced a time-dependent increase of eIF2a phos-
phorylation and the simultaneous reduction of Rad51 (Fig. 1B).
To examine whether tunicamycin-induced down-regulation of
Rad51 was due to a decrease in Rad51 mRNA, semi-quantitative
RT-PCR analysis was performed. As shown in Fig. 1C, tunicamycin
treatment did not change Rad51 mRNA levels. In addition, we also
observed that another ER stress inducer, thapsigargin, suppressed
Rad51 protein levels without affecting expression levels of other
DSB repair-related proteins (Fig. S1). These results indicate that
ER stress down-regulates Rad51 protein levels without affecting
its mRNA levels.
3.2. ER stress triggers proteasomal degradation of Rad51
We assessed the involvement of intracellular protein degrada-
tion pathways to investigate the mechanism of tunicamycin-in-
duced Rad51 down-regulation. To this end, we tested the effectFig. 1. Effect of tunicamycin on the expression levels of DSB repair-related proteins. (A) C
Cells were treated with vehicle or tunicamycin (5 lM) for the indicated times. After incu
control. (Top) Representative blots. (Bottom) The intensities of Rad51 bands were normal
⁄P < 0.05; ⁄⁄P < 0.01 vs 0 h (Student’s t-test). (C) Cells were treated with tunicamycin (5
analyzed by RT-PCR. Actin was used as an internal control.of proteinase inhibitors on tunicamycin-induced Rad51 down-reg-
ulation. Whereas 10 lM MG132, a 26S proteasome inhibitor, did
not affect basal Rad51 levels in A549 cells, it clearly inhibited
tunicamycin-induced Rad51 down-regulation (Fig. 2A). In contrast,
20 lM ALLN, a calpain inhibitor, had no effect on Rad51 levels with
and without tunicamycin treatment. In addition, we also found
that tunicamycin stimulated Rad51 ubiquitination as shown in
Fig. 2B. These results suggest that tunicamycin leads to Rad51
down-regulation through the ubiquitin–proteasome system.
3.3. ER stress attenuates DSB repair and sensitizes cells to genotoxic
stress
Because RNAi-mediated Rad51 down-regulation sensitizes tu-
mor cells to IR [10], we next analyzed whether tunicamycin treat-
ment inﬂuenced cellular radiosensitivity using a clonogenic
survival assay. The survival curves of cells exposed to X-rays is
shown in Fig. 3A. Cells pretreated with tunicamycin displayed an
increase in radiosensitivity. The 10% lethal dose (D10) of the surviv-
ing fraction was reduced from 6.85 Gy in the control cells to
5.45 Gy in the tunicamycin-treated cells (dose enhancement ra-
tio = 1.26). We further tested the effect of tunicamycin on chemo-
sensitivity of A549 cells to cisplatin and found that it was also
enhanced by tunicamycin treatment (Fig. 3B).
To elucidate the mechanism of tunicamycin-induced radiosen-
sitization, we evaluated the effect of tunicamycin on the DSB repair
capacity in irradiated cells by c-H2AX foci formation assay. Be-
cause histone H2AX is phosphorylated at serine 139 (c-H2AX)
immediately after DSB induction and forms nuclear foci [18], the
number of c-H2AX foci per cell serves as an indicator of DSBs.ells were treated with tunicamycin (TM) at the indicated concentrations for 12 h. (B)
bation, cell extracts were analyzed by Western blotting. Actin was used as a loading
ized to those of actin bands. Data are expressed as mean ± S.E. of three experiments.
lM) for 6 or 12 h. After incubation, total RNA was isolated and mRNA levels were
Fig. 2. Effect of proteinase inhibitors on tunicamycin-induced Rad51 down-regulation. (A) Cells were treated with vehicle or tunicamycin (TM) (5 lM) in the presence or
absence of the proteasome inhibitor MG132 (10 lM), or the calpain inhibitor ALLN (20 lM), for 12 h as indicated. After incubation, cell extracts were analyzed by Western
blotting. Actin was used as a loading control. (B) Immunoblot showing incorporation of ubiquitin (Ub) moieties into Rad51. Cells were treated with vehicle or tunicamycin
(TM) (5 lM) in the presence or absence of MG132 (10 lM) for 12 h, followed by immunoprecipitation and Western blotting. IP: immunoprecipitates; WCE: whole cell
extracts.
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and the formation of c-H2AX foci was analyzed. As shown in
Fig. 3C, the number of c-H2AX foci spiked 30 min after irradiation,
and then decreased in a time-dependent manner in both cell types.
No signiﬁcant effect by tunicamycin was observed in the initial
peak of the radiation-induced c-H2AX foci formation. However,
the number of c-H2AX foci decreased much more slowly in tunica-
mycin-treated cells than in control cells, suggesting the inhibition
of DSB repair by tunicamycin. Together, these data suggest that
tunicamycin sensitizes cells to genotoxic stress by suppressing
DSB repair via Rad51 down-regulation.
3.4. Glucose deprivation suppresses Rad51 levels and DSB repair
In an intratumoral environment, tumor cells are often exposed
to nutrient starvation, which leads to ER stress [3,7]. Therefore, to
examine whether nutrient stress induces the ER stress-associated
down-regulation of Rad51 and DSB repair, we tested the effect of
glucose deprivation in A549 cells. As expected, glucose deprivation
stimulated eIF2a phosphorylation, indicating a starvation-induced
ER stress (Fig. 4A). Under this condition, we observed atime-dependent decrease of Rad51 levels. In addition, treatment
with glucose-containing media did not alter the levels of either
phospho-eIF2a or Rad51. Whereas Rad51 mRNA levels were main-
tained after glucose deprivation (Fig. 4B), MG132 abrogated the
starvation-induced reduction of Rad51 protein levels (Fig. 4C). Fur-
thermore, when we evaluated the effect of glucose deprivation on
radiation-induced DSB formation, the cells under nutrient stress
had more c-H2AX foci after 1 Gy irradiation than those under nor-
mal conditions (Fig. 4D). These results suggest that nutrient stress
by glucose deprivation induces ER stress-associated down-regula-
tion of Rad51 and the reduction of DSB repair.
4. Discussion
The UPR in response to ER stress is activated in various tumors
[3,7]. Accumulating evidence suggests that the ER stress-induced
UPR is an important mechanism by which tumor cells determine
their malignancy and resulting therapy resistance [7]. Neverthe-
less, few studies have investigated how ER stress affects radiother-
apy outcomes. In the present study, we examined the radio-/
chemo-sensitivity of tumor cells that underwent ER stress and
Fig. 3. Effect of tunicamycin on cellular sensitivity to genotoxic stress and DSB
repair. (A) Cells were pretreated with or without tunicamycin (5 lM) for 12 h,
followed by X-irradiation. The cellular sensitivity to IR was assessed by clonogenic
survival assay. Data are expressed as mean ± S.E. of three experiments. ⁄P < 0.05;
⁄⁄P < 0.01 vs -tunicamycin (Student’s t-test). (B) The cellular sensitivity to cisplatin
assessed as described above. Data are expressed as mean ± S.E. of three experi-
ments. ⁄⁄P < 0.01 vs -tunicamycin (Student’s t-test). (C) Cells were pretreated with
or without tunicamycin (5 lM) for 12 h, followed by X-irradiation (1 Gy). After
irradiation, cells were collected at the times indicated to evaluate the nuclear c-
H2AX foci formation. The number of foci in at least 30 cells was scored and the
averages were plotted in the graph. Data are expressed as mean ± S.E. of three
experiments. ⁄P < 0.05; ⁄⁄P < 0.01 vs -tunicamycin (Student’s t-test).
Fig. 4. Effect of glucose deprivation on Rad51 levels and DSB repair. (A) Cells were
cultured with or without glucose for 12 h. After incubation, cell extracts were
analyzed by Western blotting. Actin was used as a loading control. (B) Cells were
cultured without glucose for 6 or 12 h. After incubation, total RNA was isolated and
the mRNA levels were analyzed by RT-PCR. Actin was used as an internal control.
(C) Cells were cultured with or without glucose in the presence or absence of the
proteasome inhibitor MG132 (10 lM) for 12 h, as indicated. After incubation, cell
extracts were analyzed byWestern blotting. Actin was used as a loading control. (D)
Cells were cultured with or without glucose for 12 h, followed by X-irradiation
(1 Gy). After irradiation, cells were collected at the times indicated to evaluate the
nuclear c-H2AX foci formation. The number of foci in at least 30 cells was scored
and the averages were plotted. Data are expressed as mean ± S.E. of three
experiments. ⁄P < 0.05 vs glucose(+) (Student’s t-test).
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(Fig. 3). Increased radiosensitivity by the chemical ER stress indu-
cer, tunicamycin, observed in this study is consistent with the data
reported by Contessa et al. [16]. We found that ER stress resulted in
the proteasomal degradation of Rad51, one of the HR proteins, and
the consequential reduction of DSB repair (Figs. 1–3). We consider
this as the central mechanism of ER stress-induced radiosensitiza-
tion because cells lacking functional Rad51 are defective in HR re-
pair and more susceptible to IR [10,11]. However, it remains
elusive how Rad51 is degraded by the ubiquitin–proteasome sys-
tem. Interestingly, gemcitabine treatment increases Rad51 ubiqui-
tination and degradation via the 26S proteasome by celecoxib (a
cyclooxygenase-2 inhibitor) or geﬁtinib (an epidermal growth fac-
tor receptor kinase inhibitor) [19,20]. These ﬁndings imply that
various treatments, not limited to ER stress inducers, might be able
to stimulate the proteasomal degradation of Rad51. An alternativepossibility is that these drugs might also cause ER stress, thereby
leading to Rad51 degradation. Further study will be required to
elucidate how ER stress causes polyubiquitination and proteaso-
mal degradation of Rad51.
We revealed in this study that, similar to tunicamycin, glucose
deprivation – a physiological condition to induce ER stress – also
resulted in the proteasomal degradation of Rad51 and the suppres-
sion of DSB repair (Fig. 4). As far as we know, this provides the ﬁrst
evidence that nutrient stress leads to inhibition of the HR pathway.
The effect of glucose withdrawal on the DNA repair machinery has
not been studied extensively. One exception is the report by Li
et al. [21], who demonstrated that glucose deprivation induces
expression of Ku70, one of the NHEJ proteins, and enhances radio-
resistance, which is at odds with our data. Here, we found no effect
of tunicamycin on the expression level of Ku70. In addition, their
results showed that glucose deprivation did not induce the ER
stress maker GRP78 in HT29 cells and DU145 cells. Together, these
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deprivation is unrelated to the glucose deprivation-induced ER
stress we observed here, providing a potential explanation for
the discrepancy between the two studies.
Although we report here what we believe are the ﬁrst data
suggesting that ER stress impairs DSB repair, hypoxia – another
physiological condition that induces ER stress – also has been
documented to decrease it [6,22,23]. Chronic hypoxia leads to
down-regulation of various HR proteins including Brca1/2 and
Rad51 [6,22,23]. It is noteworthy that chronic hypoxia reduces
Rad51 expression at the protein as well as mRNA levels,
accompanied by HR inhibition and increased radiosensitivity
[6,22]. Whereas the authors have suggested that Rad51 down-
regulation is due to transcriptional suppression, it might be
attributable, at least in part, to the enhanced degradation of
HR proteins by hypoxia-induced ER stress and ERAD. Regarding
the biological signiﬁcance of compromised DNA repair by
chronic hypoxia, Bristow et al. have suggested the possibility
that it drives tumor cells to become more malignant by acquir-
ing a mutator phenotype that consists of an increased mutation
rate and increased chromosomal instability [24]. In fact, several
groups have already reported increased mutation rates, using
mutation reporter constructs, in cells exposed in vitro or
in vivo to hypoxic conditions [25–27], supporting this idea. In
contrast, the fact that defective DNA repair in hypoxic cells
inﬂuences their radiosensitivity implies that targeting hypoxic
tumor cells with compromised DNA repair capacity could be
a potential strategy to improve therapeutic effectiveness [24].
Considering that ER stress affected cellular radiosensitivity in
a similar way as chronic hypoxia did (i.e. Rad51 down-regula-
tion and decreased DSB repair), tumor cells under ER stress
might be potential candidates to ameliorate the efﬁcacy of
radiotherapy.
In conclusion, the present study demonstrates ER stress reduces
DSB repair and enhances radiosensitivity of tumor cells via down-
regulation of Rad51 levels. The proteasomal degradation of Rad51
triggered by ER stress is highly likely to be responsible for the sup-
pression of DSB repair after IR. These ﬁndings indicate that ER
stress imposed by the intratumoral environment affects tumor
radiosensitivity and has potential as a novel target to improve can-
cer radiotherapy.Acknowledgments
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